Essex Woodlands
-
Devices & Diagnostics, Pharma, Startups
Three examples of how “the system” is changing medtech investment decisions
Will Kaiser pay for this? Kirk Nielsen of Versant Ventures said that has become the […]
-
FDA clears first “smart pill” that senses when it’s been taken, sends data to wearable patch
Behold, convergence. A startup backed by the likes of Medtronic and Novartis has combined sensors […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Renal denervation by ultrasound may set apart Kona in hypertension market
The hypertension treatment market is hot, with Medtronic leading the way in commercializing a renal […]
-
Select investors could make a killing on Medtronic/ATS Medical deal
ATS Medical Inc. (NASDAQ:ATSI) stock has been a dog for quite a while, never rising […]
-
White Pine Medical to raise $57M for medical devices fund
White Pine Medical is in the midst of a $57 million equity fundraise that will […]
-
OrbiMed Advisors raises $550M for health venture fund
OrbiMed Advisors, which has invested in Ohio companies Athersys Inc. and ViewRay, has raised $550 million for its latest health venture capital fund.
-
Former Medtronic executive starts device venture fund with Essex Woodland
Dan Lemaitre will lead the new White Pine Medical fund, which will receive a financing commitment of “up to” $50 million from Essex Woodlands Health Ventures.
-
Minnesota’s Entellus Medical gets $30M in funding
The company will use the funding to expand its sales and customer support teams, and prepare to launch its sinus-treatment system in Europe.
-
A large health fund (Essex VIII) closes and a major health investor (Google) emerges
Essex Woodlands Health Ventures’ eighth fund closed at $900 million – one of the largest ever for a health-care-only fund. At the same time, Google Ventures said its portfolio will include health-care, biotech and cleantech companies. It wants to invest $100 million in the next 12 months.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.